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Background 
Cigarette smoking is a well established risk factor for head and neck (HN) cancers. 
Use of electronic cigarettes (e-cigarettes) is gaining popularity, being advertised as 
 
 
 
 
benign alternatives to tobacco. A wide variety of potentially harmful chemical 
components with variable quantity have been identified in e-liquids and aerosols of 
e-cigarettes. However, use of e-cigarettes remains controversial due to conflicting 
evidence.
Objectives 
We aimed to assess the association between e-cigarettes and HN cancers. We 
conducted a systematic review to evaluate the literature for evidence on 
carcinogenic effects of e-cigarettes in the pathogenesis of HN cancers. 
Type of review 
Qualitative systematic review. 
Search strategy 
A Pubmed/Medline, Cochrane, CINAHL Plus, Trip medical database and Web of 
Science search was done for studies on e-cigarettes and HN cancer.  
Evaluation method 
Abstract review of all articles, full article revision of included studies, data extraction 
and quality assessment was performed by two independent assessors.  
This is the peer reviewed version of the following article: Flach, S., Maniam, P., & Manickavasagam, 
J. "E‐cigarettes and head and neck cancers: A systematic review of the current literature", Clinical 
Otolaryngology (2019), which has been published in final form at https://doi.org/10.1111/coa.13384. 
This article may be used for non-commercial purposes in accordance with Wiley Terms and 
Conditions for Self-Archiving.
This article is protected by copyright. All rights reserved. 
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Results 
The literature search resulted in the identification of 359 articles. Eighteen articles 
were selected for inclusion into the systematic review. The majority were laboratory-
based studies, followed by several cohort and case studies, representing low-level 
evidence. A few reports suggested DNA-damage following exposure to e-cigarettes 
potentially due to increased oxidative stress. Flavoured e-liquids appear to be more 
harmful. There is variable evidence from clinical studies. 
 
Conclusions 
Our review outlines potential dangers associated with the use of e-cigarettes and 
their role in HN cancers. More longitudinal and controlled studies are needed to 
assess the possible link between e-cigarettes and HN cancers. 
 
Keywords  
e-cigarettes, electronic nicotine-delivery system, electronic cigarettes, smoking, head 
and neck cancer, head and neck neoplasm, oral cancer 
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Introduction 
Head and neck (HN) cancers are a heterogenous class of diseases, which 
comprises malignancies arising from mucosal surfaces in the oral cavity, pharynx, 
larynx, paranasal sinuses, as well as tumours originating from minor and major 
salivary glands.1 The estimated numbers of new HN cancer cases and cancer 
deaths in Europe in 2018 were 161,200 (4.1% of all new cancer cases) and 72,800 
(3.8% of all cancer deaths), respectively.2  
Tobacco smoking remains a well established risk factor in the development of this 
type of cancer. Due to public health smoking cessation campaigns the incidence of 
HN cancers is slowly declining, with exception of Human Papilloma Virus-related 
cancers.1 However, over the past decade electronic cigarettes (e-cigarettes) have 
entered the market, gained in popularity, and are now increasingly advertised as 
cheaper and benign alternatives to tobacco products because they lack the 
carcinogens from the latter.3 According to results of the ASH Smokefree GB surveys 
on the use of e-cigarettes among adults in the U.K., in 2012 an estimated 700,000 
adults used e-cigarettes. In 2017 this number quadrupled to 2.9 millions (6% of the 
U.K. adult population).4 Proponents of e-cigarettes often advocate them as potential 
smoking cessation tools. A Cochrane systematic review reported evidence from two 
randomized controlled trials5,6 that e-cigarettes containing nicotine help smokers to 
stop smoking in the long term (at six months or longer) compared with placebo e-
cigarettes. No difference could be identified between the effect of e-cigarettes 
compared with nicotine patches.7 A recent multi-centre, randomized, controlled trial 
of e-cigarettes versus nicotine-replacement therapy (NRT) showed that e-cigarettes 
were more effective for smoking cessation than NRT with accompanying behavioural 
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support. However, 80% of participants who used e-cigarettes and stopped smoking 
conventional cigarettes continued to use e-cigarettes at one year.8 Contrary to these 
results, a systematic review by Kalkhoran et al.9 combining observational and clinical 
studies came to the conclusion that e-cigarettes were associated with significantly 
less quitting among smokers, suggesting that further research is needed on this 
topic. 
Also known as electronic nicotine-delivery system (ENDS) the modern e-cigarette 
was invented in China in 2003 and was introduced to the European market in 
2006.10 E-cigarettes are battery-operated devices that generate an inhalable aerosol 
by heating a solution (e-liquid) that contains a solvent (glycerin and/or propylene 
glycol), and various artificial flavours, with or without nicotine.11,12 Currently there are 
hundreds of brands and models of ENDS; by 2014 more than 460 e-cigarette brands 
and more than 7000 e-liquid flavours were available in the U.S.A. alone.10,13 To 
make it even more complicated, policies and legislations around e-cigarette product 
regulation, sale and advertisement vary widely world-wide. Until recently e-cigarettes 
were regulated in the U.K. as general consumer products without the need to report 
the content of e-liquids such as potentially harmful flavouring additives.14 New 
restrictions and requirements were introduced to  the U.K. with the Tobacco 
Products Directive 2014/14/EU from May 2016, including a minimum standard for 
safety and quality of e-cigarettes and e-liquids.15  
Despite this legislation, the safety and potential long-term effects on health of e-
cigarette use as substitute to tobacco products still remain controversial due to 
conflicting evidence in previous studies.10,14,16-29 The role of e-cigarettes in HN 
cancer patholology in particular is therefore ambiguous and inconclusive to date. Our 
study is the first attempt to describe the association between e-cigarettes and HN 
cancers. This information may help otolaryngologists to communicate the risks and 
benefits of e-cigarettes to patients and to highlight health effects relating to diseases 
of the head and neck.   
Therefore, the aim of this systematic review was to evaluate the effects of e-
cigarettes on the pathogenesis of HN cancers as reported in the literature. 
 
Methods 
 
Ethical considerations 
This study is a systematic review of previously published articles. No patient 
identifiable data was included. 
 
A systematic search was conducted using MeSH terms and other relevant keywords 
in accordance to the PRISMA (Preferred Reporting Items for Systematic reviews and 
Meta-Analyses) statement.30 The final search was carried out on 18 September 2018. 
The search strategy is detailed in Appendix S1. Table 1 illustrates inclusion and 
exclusion criteria. The level of evidence was determined according to the guidelines 
published by the Oxford Centre for Evidence-based Medicine.31 The work flow is 
illustrated in Figure 1.  
 
Results 
The initial search identified 359 potentially eligible articles. Fourty-four articles were 
provisionally selected and full reports of the relevant manuscripts were retrieved. 
These studies were supplemented by five additional articles identified by searching 
citation lists. Thirty-one articles that were initially included following abstract revision 
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failed to meet all the criteria and were excluded at the data extraction stage because 
they were not primary literature or there was no relevant data identified about e-
cigarettes and HN cancers. Eighteen articles met our inclusion criteria (Table 1) and 
were included into the final qualitative analysis which was conducted as a narrative 
synthesis as shown in Table 2.  
 
Evidence from basic research 
Thirteen of the included studies were laboratory-based investigations. Nine of these 
articles used cells derived purely from the oral cavity11,32-39 whereas one study 
worked with oropharyngeal cells and cells originated from a primary laryngeal tumour 
in addition to oral cells.40 Cultures from the middle ear41 and oropharynx42 were also 
used to investigate the effect of e-cigarettes on these cells. Cytotoxicity of e-
cigarettes in cellular experiments was demonstrated in eight studies32-35,38,40-42, with 
varying extend of DNA damage11,38,40,42 and oxidative stress induced by toxic 
components.11,32,34 Ganapathy et al.11 exposed cells to e-cigarette aerosol or 
tobacco smoke extracts. A nicotine-independent but dose-dependent increase in 
DNA damage induced by e-cigarette aerosols was observed, however, levels were 
lower than those induced by tobacco smoke extracts. Furthermore, the group 
showed that chronic exposure to e-cigarette aerosols could cause significant 
mutagenic oxidative DNA damage, with levels higher after long-term exposure to e-
cigarette aerosol than to tobacco smoke, an increase in reactive oxygen species 
(ROS) and a reduced expression of proteins essential for DNA damage repair. In a 
similar study Yu et al.40 investigated the effects of e-cigarette aerosols on a panel of 
cell lines. The in vitro study demonstrated an  increase in DNA damage, arrest in G1 
and G2, increased apoptosis, necrosis and cell death following exposure to e-
cigarette aerosols. The same group published an abstract reporting significant 
induction of DNA double-strand breaks in cells incubated with e-cigarette aerosols as 
well as an increase in migration of HN cancer cells following e-cigarette treatment 
with upregulation of epithelial-mesenchymal transition (EMT)-promoting genes.38 
Increased cell migration in dysplastic oral keratinocytes following nicotine exposure 
was also demonstrated by another group.39 Welz et al.42 treated primary 
oropharyngeal mucosal cells with e-liquids and confirmed a significant reduction in 
cell viability as well as increased DNA damage following incubation with fruit 
flavoured e-liquids. Only one study used in vivo experiments to explore the reaction 
of e-cigarettes on the vocal cords of rats. Salturk et al.43 detected hyperplasia and 
metaplasia of the laryngeal mucosa of rats following treatment with e-cigarette 
aerosols for four weeks, however, these results were not statistically significant. No 
chronic inflammatory changes were observed.  
 
Evidence from the clinic 
We identified just five clinical studies; two cohort studies27,44, two case-control 
studies45,46 and one case series47. The cohort study reported by Franco et al.27 
included 65 subjects who were divided into three groups (tobacco smokers, e-
cigarette smokers, non-smokers) and were submitted to cytologic examination by 
scraping oral mucosa. The prevalence of micronuclei was significantly decreased in 
e-cigarette smokers compared to tobacco smokers and was similar to those of 
healthy controls. A pilot study investigating the effects of e-cigarettes on blood flow in 
the buccal mucosa in 10 subjects was reported by Reuther et al.44 Here, an initial 
increase of capillary perfusion of the buccal mucosa was observed with nicotine-
containing e-cigarettes. Bardellini et al.45 enrolled outpatients for dental consultations 
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into two groups (former tobacco smokers, current e-cigarette smokers) and 
examining them for possible oral mucosal lesions (OMLs). The prevalence of OMLs 
was higher among e-cigarette smokers, however, the difference was not statistically 
significant. In terms of pre-cancerous OMLs, no difference was identified between 
the two groups. Bustamante et al.46 analysed saliva from e-cigarette smokers, 
tobacco smokers and non-smokers, and demonstrated the endogenous formation of 
the oral and oesophageal carcinogen N’-nitrosonornicotine (NNN) in e-cigarette 
smokers. Finally, a case series reported by Nguyen et al.47 described two cases of 
oral carcinoma associated with chronic e-cigarette use in otherwise healthy 
individuals. In both cases e-cigarettes were consumed 20 or 30 times per day for 13 
years and a diagnosis of basaloid squamous cell cancer (SCC) in the oral cavity was 
made. 
 
Discussion 
 
Summary and discussion of key findings 
There is some evidence suggesting a potentially carcinogenic role of e-cigarettes in 
the pathogenesis of HN cancers. Several studies commented on the cytotoxic effect 
of e-cigarettes. Korrapati et al.38 showed that short-term treatment of normal 
epithelial cells with e-cigarette aerosols induced up to five-fold increase in cell death 
without nicotine and up to 10-fold increase with nicotine as compared to untreated 
controls. Similar results were demonstrated by Yu et al.40, who, in addition to three 
other groups11,37,42, confirmed the accumulation of DNA double-strand breaks in cell 
lines exposed to e-cigarettes. Various mechanisms have been suggested to be 
involved in this process, including the generation of high levels of 8-oxo-dG11, a 
mutagenic DNA lesion, with increased presence of ROS11,34,40, known to be linked to 
single- and double-strand breaks and oxidative DNA damage, as well as a decrease 
of total antioxidant capacity and reduced expression of DNA-excision repair 
proteins11. Interestingly, flavoured e-liquids, particularly menthol, seem to be more 
harmful compared to e-liquids without flavours.36,37,41,42 Toxicants possibly 
responsible for these harmful effects have been identified in e-cigarettes. Particularly 
tobacco-specific nitrosamines (TSNAs), aldehydes, trace metals, volatile organic 
compounds, phenolic compounds, polycyclic aromatic hydrocarbons and tobacco 
alkaloids are potentially harmful and carcinogenic.48-51 Exposure to high levels of 
formaldehyde has been reported to be associated with a lifetime cancer risk 15 times 
as high as the risk associated with long-term smoking.52 In addition, it is linked to 
developing nasopharyngeal cancer, whereas TSNAs and nickel, one of the metals 
found in e-cigarette aerosol, have been implicated in oral carcinogenesis.51,53 
Overall, it is difficult to directly compare different studies because the amount of toxic 
substances varies with e-cigarette brands, e-liquid flavours and solvents as well as 
device voltage. Some studies used e-cigarette aerosols32,33,35,37,38,40,43, whereas 
others added e-liquids directly to the culture medium34,36,41,42. One would assume 
that exposure to aerosols would be more representative as fewer people would have 
direct mucosal contact with e-liquids. Most of the studies used cell lines as models 
which have the advantage of reproducability and easier maintenance compared to 
establishing primary cultures, however, it is often argued that cell lines in long-term 
culture may adapt to in vitro conditions and harbour genetic changes and 
adaptations required for their maintenance which differ from the original tissue. In a 
commentary to the article by Yu et al.40, Holliday et al.54 criticized the use of 
immortalized cell lines in addition to several methodological flaws, as well as the 
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failure to make the relevant comparisons to tobacco smoke. According to this 
commentary, the original results indicated that cells could survive longer in e-
cigarette extracts compared to cells exposed to tobacco smoke extracts.54 
Nevertheless, the question whether toxicant levels in e-cigarettes are equivalent to 
those of carcinogenic substances in tobacco smoke remains debatable. Ganapathy 
et al.11 and Welz et al.42 reported that exposure to e-cigarettes induced less DNA 
damage than the equivalent exposure to tobacco smoke. However, in both cases, 
this conclusion was only drawn from comparison to previously published data and is 
therefore error-prone due to the variability of experimental conditions and set-ups.        
Only very few studies have investigated e-cigarettes in context of HN cancers in the 
clinical environment. A case series by Nguyen et al.47 described two patients with a 
positive history of chronic e-cigarette use who developed oral cancers, indicating a 
link between the long-term consumption of e-cigarettes and this type of cancer. 
Bustamante et al.46 were able to identify a known carcinogen in the saliva of e-
cigarette smokers. Even though the overall exposure to NNN was much higher in 
tobacco smokers, it is currently not known how much of a risk even smaller amounts 
of NNN pose to e-cigarette smokers, given the carcinogenic potency of NNN. In 
contrast to these results, a study by Franco et al.27 could not identify a higher 
number of micronuclei, which are indicators of genomic instability, in e-cigarette 
smokers compared to non-smokers. Similarly, Bardellini et al.45 found no differences 
in terms of pre-cancerous OMLs between e-cigarette smokers and former tobacco 
smokers. However, both studies had small sample sizes (65 subjects divided into 
three groups27, 90 subjects divided into two groups45), limited exposure times (e-
cigarette use for at least six months), used different e-cigarette devices with various 
types of e-liquids and device voltages.  
 
Risk of biases, quality of evidence and limitations 
Only a small body of literature was identified that was relevant to e-cigarettes and 
HN cancers. 75% of studies were applicable to oral carcinogenesis and only a 
minority of the reports looked into other HN cancers. This naturally created a bias 
towards oral cavity cancer in our literature search. In addition, the focus of the 
published literature so far has mainly been on SCC. Other malignant tumours such 
as adenocarcinoma, lymphoma or salivary gland tumours were not included. 
However, this also highlights the need for additional research into other HN cancers.  
Most of the articles identified in our literature search, and described here, report 
basic laboratory experiments, either on established cell lines, primary cells or, even 
rarer, in vivo models, and so represent the lowest level of evidence. The remaining 
articles included poor-quality cohort studies with small sample sizes and limited 
exposure time, as well as case reports and case-series. They all suffered from 
limitations in their design such as the lack of proper control goups, selection bias and 
failure to account for confounding factors.  
We excluded non-English primary articles from our initial literature search, which is 
why it might be possible that we have missed other relevant publications. Due to the 
lack of high-level evidence publications and the over-representation of laboratory-
based research with a handful of case reports and poor-quality cohort studies, only 
low-level evidence could be included in this systematic review. Consequently, such 
findings are prone to biases from authors, to publication bias as well as 
ascertainment bias, and should be viewed with caution when it comes to the 
association between e-cigarettes and HN cancer pathogenesis.   
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Implications for research 
Direct health effects of exposure to tobacco smoke have been extensively studied 
but e-cigarette research is still lagging behind comparatively considering the 
popularity with consumers.  
Previous studies suggested a role for oxidative damage induced by e-cigarettes. 
Results, which need to be further investigated in order to establish whether this has 
an effect on the level of mutagenicity and hence the progression to cancer. Most 
authors rightly concluded that further research is needed to assess the effect of e-
cigarettes on health. One step forward would be to move on from in vitro to in vivo 
studies and directly compare effects of tobacco smoke with e-cigarette aerosol on a 
histological, proteomic and genomic basis. In addition, more thoroughly designed 
prospective cohort studies over longer time periods and with larger sample sizes are 
necessary to establish the safety of e-cigarettes. 
 
Implications for clinical practice 
Although based on limited quality evidence, clinicians should act on the side of 
caution when advising patients about the use of e-cigarettes. The on-going 
popularity of e-cigarettes and the continued evolution in e-cigarette-like devices55 
requires a careful evaluation of the present evidence and honest discussions with 
patients about possible benefits and risks to consider.  
 
E-cigarettes and other types of cancer 
The effects of e-cigarettes are not limited to HN cancers and there is growing 
evidence to suggest that they may play active roles in the pathogenesis of other 
malignancies such as lung and bladder cancers.56,57 For example, Lee et al. reported 
that e-cigarette aerosol exposure promotes DNA damage and impairs DNA repair in 
human lung and bladder cells, suggesting susceptibility of these cells to oncogenic 
transformation and carcinogenesis.57 Other in vitro experiments using human airway 
epithelial cells and in vivo experiments on lungs of mice have demonstrated that 
aerosol from e-cigarettes induces oxidative stress, depletes glutathione and 
upregulates the production of inflammatory cytokines.16,21 In addition, e-cigarette 
exposure has been shown to promote epithelial-to-mesenchymal transition in lung 
cancer cells, suggesting they may contribute towards metastasis in individuals at risk 
of lung cancer.58 Measurement of bladder carcinogens in the urine of e-cigarette 
users demonstrated greater concentrations of carcinogenic aromatic amines, 
suggesting a potential role of e-cigarette in the pathogenesis of bladder cancer.59 
Current research on the role of e-cigarettes in cancer focuses primarily on HN, 
bladder and lung cancers and the majority of evidence in the literature is limited to 
either in vitro or in vivo studies. The safety profile of e-cigarettes in these cancers 
needs to be evaluated further using clinical studies to better understand the 
toxicological effects of e-cigarettes in promoting carcinogenesis. 
 
Conclusion 
The current literature on the association between e-cigarettes and HN cancer 
pathogenesis is poor. There is limited evidence that e-cigarettes are harmful and 
potentially carcinogenic for the head and neck, with some reports stating that e-
cigarettes can lead to in vitro damage and that flavoured e-liquids are particularly 
damaging. There is currently no good quality evidence to conclude that e-cigarettes 
are less harmful than conventional cigarettes.  
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Keypoints 
 This is the first systematic review to explore the association between e-
cigarettes and HN cancer pathogenesis. 
 We have synthesised data from 18 studies about HN cancers and e-cigarettes. 
 Only low quality evidence from laboratory research, cohort and case studies 
was identified. 
 There is evidence that e-cigarettes can cause in vitro damage, including 
increased DNA double-strand breaks and oxidative stress. 
 E-cigarettes have only been on the European market for a bit longer than a 
decade and only recently evidence has appeared about their potentially 
harmful effects. Thus, not enough time has passed for long-term studies with 
larger cohorts and well-designed controls to emerge in the literature, or to 
draw a conclusion whether e-cigarettes play a relevant role in the 
pathogenesis of HN cancers. 
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Table 1: Inclusion and exclusion criteria. 
 
Criteria Inclusion Exclusion 
Time period No date restrictions None 
Language English Non-English 
Age  Adolescents and adults Children 
Article type All primary literature sources Secondary literature 
Study characteristics Studies that included HN (oral, 
oropharynx, pharynx, larynx, 
nasopharynx) 
cancer/dysplasia/carcinoma in 
situ of any cell type and e-
cigarettes.  
Studies that did not include HN 
cancer/dysplasia/carcinoma in 
situ and e-cigarettes. Articles on 
smoking cessation. Study 
protocols. Guidelines. Articles 
about behaviour and beliefs. 
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Study Country Evidence type and level Organ/tissue/cell type E-cigarette type Summary of author’s conclusions 
Song et al. (2018)
41
 South Korea Bench research,  
level 5 
Human middle ear 
epithelial cells (HMEECs) 
E-liquids (12 brands) Cytotoxic to cells; contain toxic heavy 
metals 
Ganapathy et al. 
(2017)
11
 
U.S.A. Bench research,  
level 5 
Human epithelial normal 
bronchial cells (Nuli1), 
human premalignant 
dysplastic oral mucosal 
keratinocyte cells (POE9n), 
human oral squamous cell 
carcinoma (UM-SCC-1) 
5 e-cigarette aerosol 
extracts from 2 device 
types (NJoy, eGo-T) 
 
Suppression of cellular antioxidant 
defenses; dose-dependent increase in 
DNA damage; potentially increased 
cancer risk 
Ji et al. (2016)
32
 U.S.A. Bench research,  
level 5 
Normal human oral 
keratinocytes (NHOKs) 
E-cigarette aerosol Cytotoxic to cells due to oxidative 
stress induced by toxic substances 
Welz et al. (2016)
42
 Germany Bench research,  
level 5 
Primary human 
oropharyngeal mucosal 
cells 
3 e-liquids (2 fruit 
flavours, 1 tobacco 
flavour) 
Cytotoxic to cells; DNA damage 
induction; potential risk factor for HN 
cancer 
Salturk et al. (2015)
43
 Turkey Bench research,  
level 5 
Female Wistar albino rats 
(vocal cords) 
E-cigarette aerosol 
(eGo-T) 
No chronic inflammation; limited 
hyperplasia and metaplasia (not 
statistically significant) 
Hwang et al. (2016)
33
 U.S.A. Bench research,  
level 5 
Human keratinocytes 
(HaCaTs) 
E-cigarette aerosol (7 
brands) 
Cytotoxic to cells 
Yu et al. (2016)
40
 U.S.A. Bench research,  
level 5 
Human keratinocytes 
(HaCaTs), human HN 
squamous cell carcinoma 
cells (HN30, UM-SCC-10B) 
E-cigarette aerosol 
(V2, VaporFi) 
Cytotoxic to cells; DNA strand break-
inducing agent; potentially 
carcinogenic 
Sancilio et al. (2015)
34
 Italy Bench research,  
level 5 
Primary human gingival 
fibroblasts 
2 e-liquids (with and 
without nicotine) 
Cytotoxic to cells; increased ROS 
production 
Rouabhia et al. Canada Bench research,  Primary human gingival EMOW e-cigarette Altered cellular morphology, 
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(2016)
35
 level 5 epithelial cells aerosol cytotoxicity, increased apoptosis and 
lactate dehydrogenase (LDH) activity 
Willershausen et al. 
(2014)
36
 
Germany Bench research,  
level 5 
Human periodontal 
ligament fibroblasts 
E-liquids (3 flavours) Harmful effect of menthol additive 
Sundar et al. (2016)
37
 U.S.A. Bench research,  
level 5 
Human periodontal 
ligament fibroblasts, human 
gingival epithelium 
progenitors, human 
gingival tissues (3D tissue 
model) 
E-cigarette aerosol 
(BLU) 
Increased oxidative/carbonyl stress, 
pro-inflammatory and pro-senescence 
responses associated with persistent 
DNA damage 
Korrapati et al. 
(2016)
38
 
U.S.A. Bench research,  
level 5 
Human epithelial and HN 
squamous cell carcinoma 
cells 
E-cigarette aerosol (2 
brands) 
Cytotoxic to cells; DNA double-strand 
break induction; increased migration of 
HN cancer cells 
Wisniewski et al. 
(2018)
39
 
U.S.A. Bench research,  
level 5 
Human dysplastic oral 
keratinocytes (DOKs), 
human Leuk-1 cells, 
human spontaneously 
immortalized normal oral 
keratinocytes (NOK-SI) 
Liquid nicotine Increased cell migration by activating 
EGFR signalling through FASN-
dependent mechanism; potential 
promoter of malignant progression in 
pre-cancerous lesions 
Franco et al. (2016)
27
 Italy Cohort study,  
level 4 
Human oral mucosa 
scrapings 
E-cigarette aerosol Decreases prevalence of miconuclei 
compared to tobacco smokers; no 
harm caused in oral cavity 
Reuther et al. 
(2016)
44
 
U.K. Cohort study, 
level 4 
Human buccal mucosa E-cigarette aerosol 
(with and without 
nicotine) 
Increased capillary perfusion of buccal 
mucosa with nicotine-containing e-
cigarette 
Bardellini et al. 
(2018)
45
 
Italy Case-control study,  
level 4 
Human oral mucosal 
lesions 
E-cigarette aerosol Linked to 3 types of inflammatory 
lesions in oral cavity (not statistically 
significant); no difference in terms of 
pre-cancerous lesions compared to 
tobacco smokers 
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Table 2: Studies investigating the association between e-cigarettes and HN cancers. 
Bustamante et al. 
(2018)
46
 
U.S.A. 
 
Case-control study,  
level 4 
Human saliva E-cigarette aerosol Endogenous formation of carcinogenic 
N'-Nitrosonornicotine inside oral cavity 
Nguyen et al. (2017)
47
 U.S.A./Vietnam Case series, 
level 4 
Oral carcinoma E-cigarette aerosol Development of oral cancer after 
chronic e-cigarette use 
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